A detailed history of Price T Rowe Associates Inc transactions in Dexcom Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,215,069 shares of DXCM stock, worth $245 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,215,069
Previous 3,449,901 6.81%
Holding current value
$245 Million
Previous $391 Million 44.9%
% of portfolio
0.02%
Previous 0.05%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$64.0 - $116.06 $15 Million - $27.3 Million
-234,832 Reduced 6.81%
3,215,069 $216 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $55.4 Million - $70.6 Million
502,461 Added 17.05%
3,449,901 $391 Million
Q1 2024

May 15, 2024

SELL
$114.22 - $140.1 $292 Million - $358 Million
-2,552,456 Reduced 46.41%
2,947,440 $409 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $163 Million - $268 Million
2,157,933 Added 64.57%
5,499,896 $682 Million
Q3 2023

Nov 14, 2023

SELL
$86.06 - $137.93 $24.1 Million - $38.6 Million
-279,688 Reduced 7.72%
3,341,963 $312 Million
Q2 2023

Aug 14, 2023

SELL
$112.47 - $130.98 $27.3 Million - $31.7 Million
-242,317 Reduced 6.27%
3,621,651 $465 Million
Q1 2023

May 15, 2023

SELL
$104.0 - $122.92 $17.7 Million - $20.9 Million
-169,956 Reduced 4.21%
3,863,968 $449 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $3.76 Million - $5.43 Million
44,260 Added 1.11%
4,033,924 $457 Million
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $7.93 Million - $9.78 Million
-103,874 Reduced 2.54%
3,989,664 $321 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $212 Million - $414 Million
3,118,722 Added 319.93%
4,093,538 $305 Million
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $31.4 Million - $43.4 Million
333,708 Added 52.05%
974,816 $499 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $4.24 Million - $5.32 Million
32,672 Added 5.37%
641,108 $344 Million
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $4.42 Million - $5.93 Million
41,392 Added 7.3%
608,436 $333 Million
Q2 2021

Aug 16, 2021

SELL
$80.99 - $107.93 $65.9 Million - $87.9 Million
-814,266 Reduced 58.95%
567,044 $242 Million
Q1 2021

May 17, 2021

SELL
$84.79 - $104.74 $64.3 Million - $79.4 Million
-757,994 Reduced 35.43%
1,381,310 $496 Million
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $167 Million - $224 Million
2,139,304 New
2,139,304 $791 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.